Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001036691 | SCV001200068 | likely benign | Epilepsy, familial focal, with variable foci 3 | 2025-01-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001664630 | SCV001874763 | likely benign | not provided | 2021-01-26 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001664630 | SCV002585526 | likely benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | NPRL3: BP5 |
Ambry Genetics | RCV003339433 | SCV004059819 | likely benign | Inborn genetic diseases | 2023-06-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Mayo Clinic Laboratories, |
RCV001664630 | SCV004227485 | uncertain significance | not provided | 2023-05-10 | criteria provided, single submitter | clinical testing | BS2 |